Novo A/S

10% owner at Metagenomi Therapeutics, Inc. · on record since Feb 15, 2024
10% owner at BIOMIMETIC THERAPEUTICS, INC. · on record since Feb 2, 2007
10% owner at MapLight Therapeutics, Inc. · on record since Oct 30, 2025
10% owner at Cyteir Therapeutics, Inc. · on record since Jun 23, 2021
10% owner at Verve Therapeutics, Inc. · on record since Jun 22, 2021
10% owner at KalVista Pharmaceuticals, Inc. · on record since Nov 30, 2016
10% owner at Avalyn Pharma Inc. · on record since Apr 29, 2026
10% owner at Hemab Therapeutics Holdings, Inc. · on record since Apr 30, 2026
10% owner at iRhythm Holdings, Inc. · on record since Oct 26, 2016
10% owner at Ra Pharmaceuticals, Inc. · on record since Oct 25, 2016
10% owner at Eargo, Inc. · on record since Oct 22, 2020
10% owner at Flexion Therapeutics Inc · on record since Dec 18, 2014
10% owner at Inogen Inc · on record since Oct 17, 2014
10% owner at IVERIC bio, Inc. · on record since Nov 17, 2014
10% owner at OnKure Therapeutics, Inc. · on record since Apr 14, 2021
10% owner at CoLucid Pharmaceuticals, Inc. · on record since May 12, 2015
10% owner at HTG MOLECULAR DIAGNOSTICS, INC · on record since May 12, 2015
10% owner at Tobira Therapeutics, Inc. · on record since May 6, 2015
10% owner at · on record since Mar 30, 2016
10% owner at · on record since May 25, 2016
10% owner at · on record since Jan 25, 2017
10% owner at · on record since Jan 4, 2017
10% owner at · on record since Sep 25, 2018
10% owner at · on record since Jun 26, 2019
10% owner at · on record since May 14, 2019
10% owner at · on record since Jul 23, 2019
10% owner at · on record since Jul 29, 2020
10% owner at · on record since Aug 25, 2020
10% owner at · on record since Jul 16, 2020
10% owner at · on record since Aug 13, 2020
10% owner at · on record since Oct 28, 2020
10% owner at · on record since Oct 22, 2020
10% owner at · on record since Oct 21, 2020
10% owner at · on record since Oct 19, 2020
10% owner at · on record since Oct 16, 2020
10% owner at · on record since Mar 31, 2021
10% owner at · on record since Feb 11, 2021
10% owner at · on record since Oct 27, 2021
10% owner at · on record since Nov 10, 2021
10% owner at · on record since Feb 9, 2022
10% owner at · on record since Jan 3, 2023

Insider trading activity of Novo A/S

Transactions on record: 903; since Feb 2, 2007

Open-market buys: 609; $344.8M

Open-market sells: 115; $491.3M

Companies traded: 46; last filing May 6, 2026

Figures computed from official regulatory filings — .

Companies where Novo A/S has traded

5 tx · May 6, 2026
7 tx · $10M · May 5, 2026
4 tx · $16.2M · Oct 30, 2025
10 tx · $16.5M · Jul 26, 2024
12 tx · $20.8M · Mar 25, 2024
5 tx · $13M · Feb 15, 2024
22 tx · $8.8M · Jul 20, 2023
1 tx · $57.6M · Jun 28, 2023
4 tx · $10.7M · Jun 23, 2023
6 tx · $15M · Sep 16, 2022
7 tx · $9.6M · Jul 15, 2022
6 tx · $7.5M · Feb 25, 2022
6 tx · $12.5M · Feb 9, 2022
5 tx · $7M · Oct 27, 2021

Track record of Novo A/S

Statistical track record

Free account

Open-market buys: 611

Last buy: May 1, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Novo A/S

Co-insiders of Novo A/S

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-62,121	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	Other	4,180,550	—	n/a (No price was disclosed in the filing)		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-71,866	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-32,695	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-23,343	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-25,899,284	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-18,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	Other	3,327,734	—	n/a (No price was disclosed in the filing)		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	Buy	555,555	18.00 USD	$10M	conv 50Cluster	SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-5,587,603	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-12,558,081	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-1,986,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	Buy	952,941	17.00 USD	$16.2M	conv 71Unusual sizeFirst in 12mo	SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-26,191,207	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	Other	2,733,681	—	n/a (No price was disclosed in the filing)		SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-19,734,671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IO Biotech, Inc.Listing unverified	Jul 26, 2024	Sell	-23,478	1.31 USD	$30.8K		SEC
IO Biotech, Inc.Listing unverified	Jul 26, 2024	Sell	-51,522	1.33 USD	$68.5K		SEC
IO Biotech, Inc.Listing unverified	May 14, 2024	Sell	-658,809	1.22 USD	$803.7K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 25, 2024	Sell	-465,021	0.75 USD	$348.8K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 20, 2024	Sell	-842,020	0.77 USD	$648.4K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 20, 2024	Sell	-359,979	0.73 USD	$262.8K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 20, 2024	Sell	-593,000	0.76 USD	$450.7K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 18, 2024	Sell	-1,912,316	0.89 USD	$1.7M		SEC
Metagenomi Therapeutics, Inc.Listing on record	Feb 15, 2024	Buy	800,000	15.00 USD	$12M	conv 49Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-62,121	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	Other	4,180,550	—	n/a (No price was disclosed in the filing)		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-71,866	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-32,695	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hemab Therapeutics Holdings, Inc.Listing unverified	May 6, 2026	OtherD (derivative)	-23,343	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-25,899,284	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-18,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	Other	3,327,734	—	n/a (No price was disclosed in the filing)		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	Buy	555,555	18.00 USD	$10M	conv 50Cluster	SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-5,587,603	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-12,558,081	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Avalyn Pharma Inc.Listing unverified	May 5, 2026	OtherD (derivative)	-1,986,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	Buy	952,941	17.00 USD	$16.2M	conv 71Unusual sizeFirst in 12mo	SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-26,191,207	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	Other	2,733,681	—	n/a (No price was disclosed in the filing)		SEC
MapLight Therapeutics, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-19,734,671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IO Biotech, Inc.Listing unverified	Jul 26, 2024	Sell	-23,478	1.31 USD	$30.8K		SEC
IO Biotech, Inc.Listing unverified	Jul 26, 2024	Sell	-51,522	1.33 USD	$68.5K		SEC
IO Biotech, Inc.Listing unverified	May 14, 2024	Sell	-658,809	1.22 USD	$803.7K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 25, 2024	Sell	-465,021	0.75 USD	$348.8K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 20, 2024	Sell	-842,020	0.77 USD	$648.4K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 20, 2024	Sell	-359,979	0.73 USD	$262.8K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 20, 2024	Sell	-593,000	0.76 USD	$450.7K		SEC
SPRUCE BIOSCIENCES, INC.Listing on record	Mar 18, 2024	Sell	-1,912,316	0.89 USD	$1.7M		SEC
Metagenomi Therapeutics, Inc.Listing on record	Feb 15, 2024	Buy	800,000	15.00 USD	$12M	conv 49Unusual size	SEC